Turning PMDA Safety Updates into Clinic Action: A Practical Workflow
A practical workflow for clinics to review PMDA safety updates, identify affected products and patients, communicate changes, and document action.
A practical guide to reviewing clinic advertising using consumer-protection principles alongside Japan’s separate medical-advertising rules.
Japan’s Consumer Affairs Agency publishes guidance on labeling, representations, and consumer-facing information. Those materials are useful for checking general principles such as clarity and avoidance of misleading claims.
Medical advertising is also subject to separate rules under healthcare law, so Consumer Affairs guidance should be treated as a supplemental reference rather than a substitute for medical-advertising requirements.
Statements about outcomes, superiority, pricing, or patient benefits should be supported by appropriate evidence and presented with the conditions needed to avoid misunderstanding.
Clinics offering private services should make it easy for patients to understand the price, what is included, and whether additional costs may arise.
Before-and-after images and patient testimonials can create a strong impression of expected results. Consent, privacy, individual variation, and the applicable medical-advertising rules all need to be considered.
Website pages, social posts, printed materials, in-clinic displays, and staff explanations should not contradict one another.
A useful compliance review asks two questions: is the statement legally permitted, and could an ordinary patient reasonably misunderstand it? Both perspectives matter.